Methylene Peptide Backbone Substitution Significantly Affects the Glycopeptide Antibiotic Cross-Linking Cascade
ACS Chemical Biology · 2026
DOI: 10.1021/acschembio.5c00944 ↗At a glance
Journal article in ACS Chemical Biology, 2026. Written by Jemma Gullick and 6 co-authors. Institution: Department of Biochemistry and Molecular Biology, the Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia. Major MEDLINE topics: Anti-Bacterial Agents, Glycopeptides, Cytochrome P-450 Enzyme System, Cross-Linking Reagents. 52 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Australian Research Council, Australian Government.
Abstract (original language)
Glycopeptide antibiotics (GPAs) are clinically important antibiotics characterized by a rigid, highly cross-linked structure. The cross-links in GPAs are installed by the activity of several cytochrome P450 (Oxy) enzymes, which are recruited to their peptide substrates by a unique domain, the X-domain. Given that this cross-linking cascade is the source of both the antibiotic activity and the synthetic complexity of GPAs, it remains a central point for exploring the tolerance of the Oxy enzymes for altered peptide substrates. In this study, we have investigated the ability of the Oxy enzymes to cross-link peptides with changes to their amide backbone, specifically a [Ψ[CH2NH]Tpg] methylene linkage that was inspired by synthetic efforts showing that such analogues can recover antibiotic activity toward resistant bacteria. Our results show that the Oxy enzymes are extremely sensitive to the presence of a methylene linkage in their peptide substrates, which suggests that these backbone carbonyl groups play a crucial role in maintaining the correct binding of peptide substrates to the P450 enzymes within the GPA cross-linking cascade.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Biochemistry and Molecular Biology, the Monash Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia.
- ARC Centre of Excellence for Innovations in Peptide and Protein Science, Clayton, Victoria 3800, Australia.
- Department of Chemistry, University of Warwick, Coventry CV4 7AL, U.K.
- The Monash Proteomics and Metabolomics Platform, Monash University, Clayton, Victoria 3800, Australia.
- Research School of Chemistry, Australian National University, Canberra, Australian Capital Territory 2601, Australia.
ORCID profiles: Ralf B Schittenhelm, Lara R Malins, Julien Tailhades, Max J Cryle
Funding
- Australian Research Council
- Australian Government
Cite
APA
Gullick, J., Marschall, E., Tucker, S., Schittenhelm, R. B., Malins, L. R., Tailhades, J., & Cryle, M. J. (2026). Methylene Peptide Backbone Substitution Significantly Affects the Glycopeptide Antibiotic Cross-Linking Cascade. ACS Chemical Biology. https://doi.org/10.1021/acschembio.5c00944
Vancouver
Gullick J, Marschall E, Tucker S, Schittenhelm RB, Malins LR, Tailhades J, et al. Methylene Peptide Backbone Substitution Significantly Affects the Glycopeptide Antibiotic Cross-Linking Cascade. ACS Chemical Biology. 2026. doi:10.1021/acschembio.5c00944
BibTeX
@article{Gullick2026,
author = {Gullick, Jemma and Marschall, Edward and Tucker, Sam and Schittenhelm, Ralf B and Malins, Lara R and Tailhades, Julien and Cryle, Max J},
title = {Methylene Peptide Backbone Substitution Significantly Affects the Glycopeptide Antibiotic Cross-Linking Cascade},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.5c00944}
}
EUVIMED